A poor response to the COVID-19 vaccination has been observed in patients with CLL and WM receiving BTK inhibitors, although as many as half of patients with CLL and WM who were treatment-naive also lacked serological response to vaccination (38, 39). Here, BTK is linked to COVID-19.